Although we did not find that KMT2D loss in HNSCC affected the expression of PER2 or IGFBP5, it is most likely that KMT2D mutation utilizes a similar mechanism to promote glycolytic gene expression. Here, PER2 is linked to head and neck squamous cell carcinoma.